Radiomics-based prediction of HCC response to atezolizumab/bevacizumab. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...
The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to ...
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80 to 85% of all cases of lung cancer. There are different stages of NSCLC, ranging from 0 to 4; ...
16, 2025 — Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials ... Jan. 3, 2025 — Tumor cells ...
Over the last years, many biological markers ... cells in urine specimens and direct visualization of the bladder mucosa with cystoscopy and resection of the tumor if identified. Bladder cancer ...
Although LAT1 is a surface marker, the team used an antibody that recognizes an intra-exosomal region ... Since the in vitro studies compared exosomes from cancer cells, Greening said that he is also ...
The movement of connected cells contributes to morphogenesis, wound healing and cancer invasion and each ... green fluorescent protein as a membrane marker). The middle panel shows human MCF ...
Cancer accounted for nearly 10 million deaths in 2020—almost one in every six deaths globally—according to the World Health Organization. Because the detection of abnormal diseased cellular growth ...
8, 2025 — An international team of UK and US scientists discovered that the activity of macrophages -- a type of white blood cell that engulf pathogens and cancer cells -- can be used to predict ...
Lung cancer is one of the most common types of cancer in the United States and a leading cause of cancer deaths. However, the timeline of how the disease progresses can vary based on several factors.